| Stocks making the biggest moves midday: Fortinet, Moderna, Intel, Bausch Health & more |
| Trump policies to boost low-end consumer into the midterms, says JPMorgan. These stocks will benefit |
| Intel's likely to still move higher. Here's a 'no-cost' options strategy to play it |
| Pardoned Binance founder Zhao says his business relationship with the Trumps was 'misconstrued' |
| A former Trump official wants to build a massive data center in a remote corner of Greenland. Will it work? |
| Intel stock drops 14% as manufacturing troubles overshadow earnings beat |
| Small cap stocks are feeling the 'January Effect.' Why the gains could continue |
| Trump's push for Greenland mineral rights could block China's access to rare earths |
| JPMorgan upgrades consumer goods stock on confidence in second-half acceleration |
| Trump sues JPMorgan, Intel's soft guidance, TikTok's joint venture and more in Morning Squawk |
| Roth says this biopharma stock has room to run on drug momentum, upcoming trial catalysts |
| Why a niche category of CRE lending is suddenly seeing record deals |
| Intel’s earnings beat couldn’t offset a weaker-than-expected outlook. Here’s what analysts are saying |
| Social Security has 'no bankruptcy or collapse in the cards,' economist says — but benefits may change |
| Advisors to the ultra rich say AI isn't a gamechanger for landing new clients |
| Stocks making the biggest moves premarket: Intel, Nvidia, SLM, Capital One & more |
| TikTok was thriving in the U.S., even before a joint venture saved it from a potential ban |
| Shares of CSG, one of the world’s fastest-growing defense firms, jump 31% on debut |
| What obesity drugmakers see next in the market: More pills, easier access and drug combinations |
| Wall Street braced for a private credit meltdown. The risk of one is rising |